Centerline Biomedical was recently chosen as one of Ohio’s top 50 most-promising startups, according to VentureOhio. VentureOhio aims to improve access to capital and foster collaboration in the startup community.
The Critical Issues in Aortic Endografting International Experts Symposium focuses on the the most pressing issues affecting minimally-invasive aortic repair
This summer Centerline Biomedical has partnered with Ohio Third Frontier as a part of their Diversity & Inclusion Technology Internship Program. This program is geared towards matching college students with early-stage technology companies to give them a real-world field related experience as well as business and entrepreneurial experiences.
Centerline Biomedical, a Cleveland Clinic spinoff, is part of this Wall Street Journal story about tech advances that are making the operating room “smarter, more effective — and a lot less risky for patients.”
Waiting for FDA clearance for your medical device can definitely feel like an eternity, but it’s important to be aware of what not to do during this process.
Complex endovascular procedures can result in higher radiation doses for both the patient and the caregiver, with variation based on several different parameters.
As we continue preparing to meet with investors, strategic partners and companies in 2018, we have successfully completed a fifth preclinical study to evaluate our surgical navigation system, IOPS.